Mayo Clinic Proceedings

Mayo Clinic Proceedings Mayo Clinic Proceedings is a premier general medicine journal. Submissions are welcome from authors w

Mayo Clinic Proceedings is a peer-reviewed medical journal published by Elsevier and sponsored by Mayo Clinic and Mayo Foundation for Medical Education and Research. In its 89th year, the Journal promotes the best interest of patients by advancing the knowledge and professionalism of the physician community and includes content from Nobel-prize-winning research. The Journal has an impact factor of 6.262, is ranked 11th of 153 journals in the General/Internal Medicine category, and reaches more than 125,000 physicians. Media coverage reaches a potential audience of more than 4 million per day and approximately 1 billion annually. The Journal welcomes submissions from authors worldwide, publishing articles that focus on clinical medicine and support the professional and educational needs of its readers. The time from receipt to first decision of a manuscript is usually 3 weeks and from acceptance to publication 12 weeks. The Journal's acceptance rate is approximately 15%, with more than 80% of manuscripts submitted by non-Mayo authors. For novel, time-sensitive research, an expedited review is available upon request and at the discretion of the Editorial Board. Mayo Clinic Proceedings carries individual articles and features each month, consisting of original research, reviews, clinical content, editorials, commentaries, brief reports, special articles, and other short items. The Journal also offers unique features such as Concise Review for Clinicians, Residents' Clinics, and specially commissioned Symposia. In addition, Proceedings includes articles with free CME credit from Mayo Clinic. Finally, the Journal carries online-only content such as Historical Vignettes, Stamp Vignettes, and Art at Mayo, as well as supplemental material and videos directly related to the individual articles.

CME offered: Insomnia is strictly a clinical diagnosis and is not one that requires a sleep study (eg, home sleep apnea ...
02/19/2026

CME offered: Insomnia is strictly a clinical diagnosis and is not one that requires a sleep study (eg, home sleep apnea test, in-laboratory polysomnography) to be established.
https://mayocl.in/3MJs5Nk

02/18/2026

A minute with Dr Abdalla as he discusses the potential of cannabidiol for treating cardiovascular diseases.
https://bit.ly/40gYvC5

In the latest edition of Tomorrow's Cure podcast, medical pioneers share their amazing work. What they describe may soun...
02/11/2026

In the latest edition of Tomorrow's Cure podcast, medical pioneers share their amazing work. What they describe may sound like science fiction but watch and you will find the future of medicine is already here.
https://mayocl.in/3NHnaN7

The same mechanisms responsible for lorlatinib’s superior central nervous system antineoplastic effects also appear resp...
02/10/2026

The same mechanisms responsible for lorlatinib’s superior central nervous system antineoplastic effects also appear responsible for troubling neurocognitive adverse events.
https://mayocl.in/4kpDTRo

This study revealed that mavacamten therapy was associated with an approximately 50% lower risk of the composite cardiov...
02/09/2026

This study revealed that mavacamten therapy was associated with an approximately 50% lower risk of the composite cardiovascular outcome compared with medical management in patients with obstructive hypertrophic cardiomyopathy.
https://mayocl.in/4ribkYA

More than 10 cortisone-related papers and Dr Philip Hench's reflections on the Nobel Prize celebration have been publish...
02/06/2026

More than 10 cortisone-related papers and Dr Philip Hench's reflections on the Nobel Prize celebration have been published in Mayo Clinic Proceedings, making our journal one of the most important channels for disseminating the discovery of cortisone.
https://mayocl.in/4tDCWJF

This review delves into the limitations, identifying key research gaps and future directions needed to establish the cli...
02/05/2026

This review delves into the limitations, identifying key research gaps and future directions needed to establish the clinical utility, safety, and therapeutic efficacy of cannabidiol in cardiovascular medicine.
https://mayocl.in/4rqqn2i

Medical image: Bullous pemphigoid, the most common autoimmune blistering disease, is characterized by autoantibodies aga...
01/28/2026

Medical image: Bullous pemphigoid, the most common autoimmune blistering disease, is characterized by autoantibodies against bullous pemphigoid antigen 180, a hemidesmosomal protein involved in its pathogenesis.
https://mayocl.in/4qSrUym

Address

Siebens Bldg # 770
Rochester, MN
55905

Opening Hours

Monday 7am - 5pm
Tuesday 7am - 5pm
Wednesday 7am - 5pm
Thursday 7am - 5pm
Friday 7am - 5pm
Saturday 7am - 5pm
Sunday 7am - 5pm

Alerts

Be the first to know and let us send you an email when Mayo Clinic Proceedings posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category